Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12612451 | Method of treating neuromyelitis optica spectrum disorder (NMOSD) comprising administering an anti-C5 antibody | 🖼🧊📄§ | 2026-04-28 | 2040-12-08 | 0 | 31 |
| 12612456 | CD19 antibodies and methods of using the same | 🖼🧊📄§ | 2026-04-28 | 2040-04-07 | 0 | 31 |
| 12612459 | Methods of identifying agents that block MCD28 cleavage by MMPS | 🖼🧊📄§ | 2026-04-28 | 2040-12-02 | 0 | 31 |
| 12612454 | Canine antibody variants | 🖼🧊📄§ | 2026-04-28 | 2041-09-28 | 0 | 31 |
| 12612467 | Treatment of necrotizing enterocolitis with semisynthetic polyclonal human secretory immunoglobin A | 🖼🧊📄§ | 2026-04-28 | 2042-09-21 | 0 | 31 |
| 12612469 | Fusion polypeptide comprising polypeptide region that can be O-glycosylated | 🖼🧊📄§ | 2026-04-28 | 2039-09-04 | 0 | 31 |
| 12612465 | Formulations comprising PCSK9 specific monoclonal antibodies | 🖼🧊📄§ | 2026-04-28 | 2033-05-02 | 0 | 31 |
| 12612599 | Compositions and methods for microglia replacement therapy | 🖼🧊📄§ | 2026-04-28 | 2039-09-10 | 0 | 31 |
| 12612439 | Mutant bacteriorhodopsin-like-channelrhodopsin ion channel | 🖼🧊📄§ | 2026-04-28 | 2043-02-03 | 0 | 31 |
| 12612576 | Production of oils from palm bark | 🖼🧊📄§ | 2026-04-28 | 2044-02-13 | 0 | 31 |
| 12612440 | Modified bovine G-CSF polypeptides and their uses | 🖼🧊📄§ | 2026-04-28 | 2042-12-22 | 0 | 31 |
| 12611399 | Movement disorders | 🖼🧊📄§ | 2026-04-28 | 2042-05-01 | 0 | 31 |
| 12611439 | Ionic self-assembling peptides | 🖼🧊📄§ | 2026-04-28 | 2043-02-09 | 0 | 31 |
| 12611407 | Gastro-resistant high-strength formulation containing posaconazole | 🖼🧊📄§ | 2026-04-28 | 2041-08-13 | 0 | 31 |
| 12611409 | Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor | 🖼🧊📄§ | 2026-04-28 | 2042-03-15 | 0 | 31 |
| 12611423 | Medical use of tafoxiparin | 🖼🧊📄§ | 2026-04-28 | 2043-05-02 | 0 | 31 |
| 12612463 | Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors | 🖼🧊📄§ | 2026-04-28 | 2044-01-19 | 0 | 31 |
| 12612462 | Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding IL33 and IL1RL1 | 🖼🧊📄§ | 2026-04-28 | 2043-06-07 | 0 | 31 |
| 12612424 | HPK1 inhibitors and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-07-03 | 0 | 31 |
| 12612403 | Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-04-28 | 2045-08-26 | 0 | 31 |
| 12612405 | Crystalline form of 1-(8-Bromopyrido[2,3-E][1,2,4]triazolo[4,3-a]pyrazin-4-Yl)-Nmethylazetidin-3-amine hydrogen sulfate monohydrate | 🖼🧊📄§ | 2026-04-28 | 2042-03-29 | 0 | 31 |
| 12612408 | Pyrazolone-fused pyrimidine compound, preparation method for same and applications thereof | 🖼🧊📄§ | 2026-04-28 | 2040-06-28 | 0 | 31 |
| 12611456 | Use of thiazole amide compounds for modulating human immune response | 🖼🧊📄§ | 2026-04-28 | 2040-09-16 | 0 | 31 |
| 12611459 | System and method for unbinding of plasma protein-bound active agents using an ultrasound system | 🖼🧊📄§ | 2026-04-28 | 2040-06-05 | 0 | 31 |
| 12611460 | Eyedrop compositions | 🖼🧊📄§ | 2026-04-28 | 2039-09-18 | 0 | 31 |
| 12611463 | Methods and immunogenic compositions relating to HER2 with selective sequence modifications | 🖼🧊📄§ | 2026-04-28 | 2043-12-04 | 0 | 31 |
| 12611464 | Modified clostridial neurotoxins as vaccine and conjugate vaccine platforms | 🖼🧊📄§ | 2026-04-28 | 2042-10-03 | 0 | 31 |
| 12611465 | Protein-enclosing polymeric micelle | 🖼🧊📄§ | 2026-04-28 | 2045-03-14 | 0 | 31 |
| 12611369 | Skin mimicry compositions and implants | 🖼🧊📄§ | 2026-04-28 | 2042-11-23 | 0 | 31 |
| 12611377 | Pharmaceutical composition comprising an androgen receptor inhibitor | 🖼🧊📄§ | 2026-04-28 | 2043-12-27 | 0 | 31 |
| 12611379 | Lipid nano drug delivery system targeting brain lesion and preparation method and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-13 | 0 | 31 |
| 12611380 | Solution and method for reducing the virulence of viruses, bacteria, yeasts, or fungus | 🖼🧊📄§ | 2026-04-28 | 2041-11-18 | 0 | 31 |
| 12611381 | Cationic hyaluronic acid coated spanlastics and preparation and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-04-02 | 0 | 31 |
| 12611382 | Method for manufacturing lipid particle | 🖼🧊📄§ | 2026-04-28 | 2042-09-09 | 0 | 31 |
| 12611496 | Peritoneal dialysate fluid generation system | 🖼🧊📄§ | 2026-04-28 | 2039-06-28 | 0 | 31 |
| 12611400 | Solid lipid nano-composition containing berberine and cinnamonaldehyde effective in treating diabetes, dyslipidemia, and method of preparing the same | 🖼🧊📄§ | 2026-04-28 | 2040-12-04 | 0 | 31 |
| 12611426 | Antibiotic composition comprising a composite of diatomaceous earth and zinc oxide, and combination preparation with the same | 🖼🧊📄§ | 2026-04-28 | 2042-07-07 | 0 | 31 |
| 12611428 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-04-28 | 2040-12-02 | 0 | 31 |
| 12611640 | Continuous flow microfluidic system | 🖼🧊📄§ | 2026-04-28 | 2044-02-06 | 0 | 31 |
| 12611443 | Methods and compositions related to therapeutic peptides for cancer therapy | 🖼🧊📄§ | 2026-04-28 | 2041-06-14 | 0 | 31 |
| 12605467 | Recombinant AAV vectors for treating neurodegenerative disorders | 🖼🧊📄§ | 2026-04-21 | 2044-10-18 | 0 | 31 |
| 12605430 | High-activity blood coagulation factor XI mutant Ala570Thr | 🖼🧊📄§ | 2026-04-21 | 2041-04-13 | 0 | 31 |
| 12605338 | Method for preparing nano-immune activator, article and use thereof | 🖼🧊📄§ | 2026-04-21 | 2043-11-01 | 0 | 31 |
| 12605388 | Lamotrigine salts, co-crystals, and compositions | 🖼🧊📄§ | 2026-04-21 | 2045-02-14 | 0 | 31 |
| 12605409 | Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders | 🖼🧊📄§ | 2026-04-21 | 2043-04-14 | 0 | 31 |
| 12605359 | Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor and pharmaceutical use therefor | 🖼🧊📄§ | 2026-04-21 | 2041-01-27 | 0 | 31 |
| 12605335 | Triptolide lignocerate, liposome thereof and preparation method therefor | 🖼🧊📄§ | 2026-04-21 | 2043-05-16 | 0 | 31 |
| 12605435 | Multivalent pneumococcal polysaccharide-protein conjugate composition | 🖼🧊📄§ | 2026-04-21 | 2044-01-23 | 0 | 31 |
| 12605405 | Methods for the production of pharmaceutical agents | 🖼🧊📄§ | 2026-04-21 | 2039-08-22 | 0 | 31 |
| 12605427 | Sublingual semaglutide-BPC 157 combination for weight loss | 🖼🧊📄§ | 2026-04-21 | 2043-05-15 | 0 | 31 |